Factors and methods for reducing biological activity of a...

Family of 28 kda babesia proteins as vaccines

Fap-activated anti-tumor compounds

Fap-activated anti-tumor compounds

Fas antagonists and uses thereof

Fas binding antibodies

Fas peptide mimetics and uses thereof

Fatty acid carriers for synthetic vaccines

Fatty acid synthase mrna binding protein

Fatty acid-pulmonary surfactant conjugates

Fc receptor binding proteins

Fc receptor-binding polypeptides with modified effector...

Fc region variants

Fc variants with altered binding to fcrn

Fc variants with altered binding to fcrn

Fc variants with altered binding to fcrn

Fc variants with optimized fc receptor binding properties

Fc variants with optimized properties

Fc-erythropoietin fusion protein with improved pharmacokinetics

Fc-fusion constructs binding to phosphatidylserine and their...